About this trial
The advances in early detection coupled with improvements in treatments have led to an ever-increasing number of breast cancer survivors. New methods to improve outcomes, including strategies aimed at improving the quality of life and reducing the risk of other diseases, may represent valid additions to the currently available treatment options. Interventions targeting diet, weight and physical activity can reduce the risk of cancer occurrence, prevent cancer recurrence, improve survival and the quality of life.
This is an observational, prospective study aimed at evaluating the effects of physical activity on the quality of life of patients with early stage hormone receptor positive breast cancer receiving adjuvant hormonal therapy and adhering to a physical activity program lasting for a total of 12 weeks organized by ANDOS onlus (Associazione Italiana Donne Operate al Seno).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with early stage (I-IIIa) hormone receptor-positive breast cancer receiving adjuvant endocrine therapy
Female patients ≥18 years of age
Written informed consent must be obtained before any study-related assessment is performed
Participation to the Medicina and Sport physical activity program organized by Andos Pordenone
Disqualifiers
Patients with early hormone receptor negative breast cancer
Patients with early hormone receptor positive breast cancer receiving chemotherapy
Patients with advanced/metastatic breast cancer.
Patients receiving active treatment for secondary primary tumors (excluding basal cell carcinoma or in situ neoplasias).
Trial population
Early stage hormone receptor positive breast cancer patients participating to the Medicina and Sport
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Change in Quality of Life as measured by the EORTC QLQ-C30 questionnaire.
Mean differences on the questionnaire will be evaluated. The EORTC QLQ-C30 (European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire) is a 30-item validated tool used to assess the physical, psychological, and social functions of cancer patients. Higher scores on functional scales and the global health status represent a higher/better level of functioning, while higher scores on symptom scales represent a higher level of symptomatology.
Secondary outcomes
Change from Baseline in Pain Intensity (Brief Pain Inventory - Short Form)
Pain intensity will be assessed using the Brief Pain Inventory (BPI) Severity score, rated on an 11-point Likert scale from 0 (no pain) to 10 (pain as bad as you can imagine). A higher score indicates greater pain intensity.
Change from Baseline in Physical Activity Levels
Subjective physical fitness and activity will be evaluated using the IPAQ (International Physical Activity Questionnaire). This questionnaire assesses walking, moderate-intensity, and vigorous-intensity activities. Results are reported as Metabolic Equivalent of Task (MET)-minutes per week. Higher MET-minutes indicate higher physical activity levels.
Change from Baseline in Dietary Habits and Nutritional Intake
Evaluated through food diaries provided during nutritional visits. The diaries assess caloric intake and macronutrient distribution (carbohydrates, proteins, fats).
Change from Baseline in Blood Test Results
Difference in mean of laboratory parameters as collected during routine nutritional visits to assess the metabolic impact of the program.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.